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Commentary
More than 200,000 new cases of invasive
breast cancer and 55,000 cases of in situ dis-
ease are diagnosed annually in the United
States (American Cancer Society 2003), and
U.S. women’s lifetime risk of breast cancer has
doubled from about 1 in 14 in the 1960s to
1 in 7 today, or 1 in 6 including in situ disease
(Ries et al. 2004). Incidence continues to rise
incrementally in the United States (Ries et al.
2004), and it is increasing more rapidly in
developing nations (Parkin et al. 2001). High
incidence makes breast cancer an urgent public
health priority, and because an increased risk
over just one generation must reﬂect modiﬁ-
able change rather than inherited genes, inci-
dence patterns also signal that breast cancer is a
realistic target for prevention. Further evidence
comes from a study of women with high-risk
BRCA1 and BRCA2 genetic variations that
showed that 24% of women born before 1940
were diagnosed with breast cancer by age 50,
compared with 67% of women born later,
indicating that modiﬁable factors affect even
women at high genetic risk (King et al. 2003).
Factors affecting estrogen and progesterone
are among the best-established risk factors for
the disease. These include age at menarche and
menopause, parity, age at ﬁrst full-term preg-
nancy, weight gain after menopause, hormone
replacement therapy, lack of physical activity,
and alcohol use (Bernstein 2002). These effects,
although relatively weak, consistently appear
in many epidemiologic studies, leading to
high conﬁdence in their roles as risk factors.
A much more limited inquiry into chemical
exposures as breast cancer risk factors provides
a new hypothesis for study: Laboratory animal
and cell studies support the hypothesis that
animal mammary carcinogens and chemicals
that mimic estrogen or otherwise disrupt hor-
mones may increase breast cancer risk, just as
endogenous and pharmaceutical hormones do
(Brody and Rudel 2003; Davis et al. 1993;
Wolff et al. 1996). Exposures to mammary
carcinogens and endocrine-disrupting com-
pounds (EDCs) are common from sources
such as gasoline, pesticides, detergents, plastics,
home furnishings, personal care products, and
air and water pollution (Brody and Rudel
2003; Rudel et al. 2003).
In the early 1990s, a number of breast
cancer activist organizations began pursuing
research into these environmental pollutants
as possible avenues to breast cancer preven-
tion (Brown et al., in press; McCormick et al.
2003). They won Congressional legislation
mandating the Long Island Breast Cancer
Study Project (LIBCSP) (U.S. Congress
1993), founded Silent Spring Institute as an
independent organization dedicated to breast
cancer and environment research (Brody et al.
1996), and later initiated a multicenter
National Institute of Environmental Health
Sciences (NIEHS) program of research into
environmental factors in the course of
puberty in girls (NIEHS 2003).
The design of epidemiologic studies to
address activist concerns is problematic, how-
ever, particularly because the exposure assess-
ments themselves pose challenges (Brody and
Rudel 2003). Self-reports, the basis for expo-
sure classification in studies of most known
breast cancer risk factors, are at best a weak
method for assessing exposure to many pollu-
tants. Randomized clinical trials, the source of
most knowledge about the effects of exogenous
chemicals on breast cancer, effectively measure
pharmaceutical exposures but are not an ethi-
cal option for exposures from pollution, work-
places, or consumer products. Biomarkers of
exposure and sampling methods for environ-
mental media, such as air, water, and food,
have been developed for relatively few of the
many chemicals hypothesized to affect breast
cancer. They are expensive to use in studies
large enough to detect risks of the magnitude
(probably < 2-fold) we would expect for EDCs
based on the relative risks for known hormonal
risk factors. Also, they are difficult to apply
across the life span, a problem because higher
breast cancer risk is associated with hormonal
exposures beginning in utero (e.g., twinning
and maternal diethylstilbestrol use) and
extending to within 5 years of diagnosis (e.g.,
pregnancy and hormone replacement therapy).
Finally, strategies for aggregating effects of
mixtures have yet to be developed.
Given these challenges, as activist-generated
breast cancer research unfolded, tensions
emerged from the mismatch between what
investigators can achieve through prevailing
epidemiologic research paradigms and what
activists had hoped to accomplish in time to
help their daughters. Lessons from these con-
ﬂicting perspectives carry many parallels with,
and can inform, other health issues for which
relevant exposures are similarly difficult to
assess and where disease has multifactorial cau-
sation (e.g., asthma and learning disabilities).
In this commentary, we seek to draw out these
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activist goals and scientiﬁc methods in refer-
ence to the precautionary principle, because it
provides a framework for generalizing from the
breast cancer studies to other public health
issues where scientiﬁc uncertainty is likely to
persist. We focus particularly on the Cape Cod
Breast Cancer and Environment Study,
because two of us have been involved for nearly
a decade in its development and implementa-
tion (J.G.B. as principal investigator and
R.A.R. as co-investigator for toxicology and
environmental science). We also comment on
the Long Island study and the NIEHS breast
cancer and environment research centers pro-
gram. The Bay Area Breast Cancer and the
Environment Study Group and research in
Marin County, California, which offers another
early example, is now affiliated with the
NIEHS centers program.
Precaution as a Guide to
Environmental Health
Research Design
The precautionary principle calls for preventive
action in the face of uncertain but suggestive
evidence of risk, especially when safer alterna-
tives exist. The 1998 Wingspread Statement
on the Precautionary Principle (Raffensperger
and Tickner 1999) identiﬁes four central com-
ponents of precautionary policies: a) taking
preventive action in the face of uncertainty,
b) placing responsibility on those who create
risks to study and prevent them, c) considering
alternatives to potentially harmful activities,
and d) increasing public participation and
transparency in decision making. In contrast,
current U.S. chemical regulations require sub-
stantial evidence of harm before regulatory
action is taken, regardless of the availability of
alternatives.
Previous discussions have outlined how
the precautionary principle calls for changes
in research process, questions, interpretations,
and policy applications (Kriebel et al. 2001;
Stirling and Gee 2002; Tickner 2002, 2003).
By approaching public health policy with a
greater willingness to act in the face of uncer-
tainty, the precautionary principle expands
the scope of relevant science and increases the
utility of evidence about hypothesized harms
even when that evidence is far from deﬁnitive.
It calls for assessment of the “strength of evi-
dence” that accrues from a broadly defined
toolbox of methods that includes typical
hypothesis-testing epidemiologic designs and
extends to hypothesis-generating epidemiol-
ogy, toxicology, exposure assessment, risk
assessment, wildlife studies, and human case
reports. Precautionary science seeks integra-
tive methods to deal with chemical mixtures
and multiple health effects from the same
exposure. It implies an iterative process of
research and policy making with an explicit
role for judgment, which in turn argues for
democratization.
Many breast cancer activist organizations,
including groups involved in the Long Island
and Cape Cod studies, have explicitly endorsed
the precautionary principle {examples come
from New York (Huntington Breast Cancer
Action Coalition 2003), California (Breast
Cancer Action 2004), Massachusetts [Massa-
chusetts Breast Cancer Coalition (MBCC)
2004], and Oregon (Crumpacker 2002)}. The
history of community-initiated breast cancer
studies reflects the influence of the activists’
precautionary thinking on expanding the
scope of research and strategies for public
involvement.
Public Participation in 
Decision Making
Increased public participation and trans-
parency in decision making are a logical start-
ing point for applying the precautionary
principle to breast cancer studies because
democratizing scientific research opens the
door for activists’ priorities to inﬂuence study
design. Breast cancer activists, following the
example of AIDS activists, have become leaders
in helping to drive research agendas by catalyz-
ing federal and state legislation and appropria-
tions and participating in research design
(Brown et al. 2000; McCormick et al. 2003,
2004). In 1993 and 1994, Long Island and
Massachusetts activists initiated unprecedented
public roles in research by seeking empower-
ment in study design and implementation.
Frustrated that decades of the war on cancer
had not addressed their questions about envi-
ronmental factors and prevention, both groups
circumvented traditional federal grant making
and sought help through elected ofﬁcials. Long
Island activists generated the first large-scale
breast cancer and environment research through
a congressional mandate, and the Cape Cod
study, funded by the state legislature, pioneered
activist governance in research.
Long Island study. The LIBCSP was the
ﬁrst of the activist-generated studies to become
nationally visible. Mandated by Congress in
1993, it grew to encompass > 10 studies total-
ing > $30 million. Beyond winning funds,
the Long Island activists specified in the
Congressional mandate several aspects of the
research design, including a case–control study
using biologic markers and the development
of a geographic information system (GIS)
(U.S. Congress 1993). The grants were then
awarded to academic scientists, however, and
activists sometimes felt shut out of the process
(McCormick et al. 2003). For example, con-
ﬂict emerged about the list of environmental
pollutants under study, with activists advo-
cating for a more extensive set of target com-
pounds (Balaban B, personal communication).
The academics, motivated partly by the limited
availability of biomarkers for historical expo-
sure, chose to study organochlorines that had
been banned in the United States, generating
data that would not directly inform current
environmental health policy. In addition,
hopes that the GIS would allow activists to
extend community-based mapping efforts were
dashed by delays and limits on public access to
many types of data.
Cape Cod study. The Cape Cod Breast
Cancer and Environment Study also began
from a legislative mandate (General Court of
the Commonwealth of Massachusetts 1994),
although at the state rather than federal level.
In response to Massachusetts Department of
Public Health (MDPH) data showing elevated
incidence on Cape Cod (Brody et al. 1996),
MBCC founded Silent Spring Institute in
1994 to bid for and win a $1 million annual
state appropriation for breast cancer and envi-
ronment research. The institute’s researchers in
epidemiology, toxicology, and environmental
science now collaborate with co-investigators
from Boston, Brown, Harvard, and Tufts uni-
versities and elsewhere.
The founders’ vision transcended “science
as usual” and gave activists governance roles on
the scientific team. As a nonprofit organiza-
tion, the institute has a public-interest board of
directors (including three directors chosen as
MBCC representatives) with the authority to
hire and ﬁre the study’s principal investigator.
The board’s authority is tempered by grant
requirements for funder approval before key
personnel can be replaced, however, and the
Silent Spring Institute board developed addi-
tional mechanisms to ensure that it exercises its
authority responsibly. The board convened a
science advisory committee of outside experts,
frequently sent a representative to co-investiga-
tor meetings, gave added weight to input from
board members trained in biology and medi-
cine, and supported publication of research
results in peer-reviewed scientiﬁc journals even
when MDPH disallowed use of state funds for
this purpose. This activist-governed research
model is particularly notable at a time when
government increasingly relies on industry
science in regulatory decisions and academic
science is growing more dependent on industry
funding (Krimsky 2003). Further, breast can-
cer activists often cite their hope of putting
themselves out of business by ﬁnding scientiﬁc
answers to “stop the epidemic,” so their gover-
nance role may help check any possible bias
stemming from researchers’ interests in perpet-
uating their own work.
NIEHS Centers. The NIEHS Centers
program began as an initiative of the National
Breast Cancer Coalition, which, along with
NIEHS, convened a series of invitational
brainstorming sessions for researchers and
activists. These sessions, coupled with public
meetings, shaped the request for applications
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approach, including laboratory and epidemio-
logic components, and required ongoing pub-
lic involvement (NIEHS/National Cancer
Institute 2002).
Among these three examples of activist-
initiated research, the Cape Cod and NIEHS
models have extended the democratization of
science in ways that can offer models for the
development of new norms for environmental
health research: public empowerment that goes
beyond mere involvement on advisory boards,
a shift away from purely investigator-deﬁned
research to joint activist–scientist deﬁnition of
research problems, and integration across disci-
plines and across institutions. The Cape Cod
study is perhaps unique even in the history of
community-based participatory research in
that activists govern the research team.
Research Questions and 
Study Design
If democratization in science makes a differ-
ence, we would expect to see activist-initiated
studies that differ in design from the typical
investigator-initiated studies funded by the
National Cancer Institute, Department of
Defense, and major foundations. Consistent
with breast cancer activists’ support for the pre-
cautionary principle, we expect study designs
that will inform preventive public health poli-
cies in the face of uncertainty [the ﬁrst prin-
ciple of the Wingspread Statement on the
Precautionary Principle (Raffensperger and
Tickner 1999)]. The research that serves this
goal includes assessments of such factors as
“upstream” health outcomes (e.g., precursors
of disease), multiple sources of uncertainty
in measurements and models, effects on sensi-
tive individuals, the nature and effects of high
exposures, exposure pathways, cumulative and
interactive effects of multiple exposures, popu-
lation as well as individual effects, and the
environmental justice implications of the dis-
tribution of health risks across exposure levels
and across populations (Kriebel et al. 2001;
Stirling and Gee 2002; Tickner 2002, 2003).
We add to this list of relevant research activities
the development and application of animal
and cell models that can inform understanding
of natural systems and the plausibility of effects
in humans (Brody and Rudel 2003). If EDCs
make breast cancer cells grow in the laboratory,
for example, they may also affect breast cancer
in women. Animal and cell studies are particu-
larly valuable when human studies are techni-
cally or ethically difﬁcult to undertake.
Long Island study. The Breast Cancer and
the Environment on Long Island case–control
study, the centerpiece of the LIBCSP, applied
a typical hypothesis-testing framework to
investigate whether an association exists
between breast cancer risk and organochlorine
compounds [dichlorodiphenyltrichloroethane
(DDT)/dichlorodiphenyldichloroethylene
(DDE), chlordane, dieldrin, and polychlori-
nated biphenyl], which are EDCs, and poly-
cyclic aromatic hydrocarbons (PAHs), which
are mammary carcinogens (Gammon et al.
2002a, 2002b). From the perspective of a pre-
cautionary science model, the choice of expo-
sures for study is mixed. The organochlorine
compounds are banned in the United States,
so ﬁndings are not directly actionable, but if
the study had shown an effect, it would have
strengthened the existing evidence from stud-
ies of pharmaceutical estrogens that exogenous
hormones contribute to breast cancer, adding
support for precautionary action regarding
other EDCs. PAHs—the source of ubiquitous
and avoidable exposure from grilled and
smoked foods, tobacco smoke, and air pollu-
tion from vehicle exhaust and other fossil fuel
burning—have clear action implications.
Aside from the choice of target com-
pounds, case–control studies can serve public
health decision making by generating an esti-
mate of relative risk and its conﬁdence inter-
val. However, we consider this a high-risk
strategy in both the Long Island and Cape
Cod studies from a precautionary perspective,
because of the considerable expense coupled
with the likelihood of generating inconclusive
negative findings, which are common in
case–control studies of hard-to-assess expo-
sures to pollutants in the general population.
Several factors favored the potential in the
LIBCSP to produce persuasive evidence that
organochlorines increase breast cancer risk:
the biologically plausible hypothesis that
EDCs affect breast cancer, several earlier stud-
ies showing an association between breast
cancer and serum organochlorines, a large
sample size (providing good statistical power
to detect an effect), rapid case ascertainment
(so serum measures could not be affected by
breast cancer treatment), extensive interviews
about established and hypothesized breast
cancer risk factors (to control for confound-
ing and investigate effect modification), and
individual-level biologic markers of exposure.
On the other hand, results that failed to show
an association could contribute little, because
study design limitations mean we cannot con-
clude from null results that no association
exists. For example, no one in the study can
reasonably be considered unexposed, raising
questions about whether there is adequate
exposure variability to detect effects. In addi-
tion, the one-time exposure measures do not
accord well with the evidence that timing in
the life cycle is important in breast cancer eti-
ology. Speciﬁcally, serum measures taken near
the time of diagnosis may not represent early
life exposures or even total lifetime exposure,
because recent levels are inﬂuenced by variables
related to mobilization and excretion, such as
weight gain/loss and lactation, and by intake of
breakdown products in food that have differ-
ent toxicologic properties from the parent
compound (e.g., DDE, which is ingested in
meat and dairy, is less estrogenic than the par-
ent compound DDT) (Brody and Rudel 2003;
Snedeker 2001). Results did not show an asso-
ciation between recent serum measures and
breast cancer (Gammon et al. 2002b).
The Long Island study reported 50%
higher breast cancer risk among women with
the highest levels of DNA damage from
selected PAHs, statistically significant at the
traditional p < 0.05 level, but with no linear
dose response (Gammon et al. 2002a). It now
falls to the public and policy makers to evaluate
whether this result supports precautionary
steps to reduce exposure, particularly in light of
other evidence of health damage from PAHs
and available alternatives to reduce exposure.
This decision is hindered, however, because the
biologic exposure measure does not reveal the
exposure source where policies might be
designed to intervene. The DNA adduct meas-
ure was poorly correlated with self-reported
dietary and tobacco sources, leaving us to spec-
ulate that air pollutants may be an important
source. It is also useful to consider the policy
implications if air pollutants are an important
source. The study’s effect size—50% higher
breast cancer risk with high PAH DNA dam-
age—is sometimes considered small in epi-
demiology but is nevertheless larger than the
estimated 30% reduction in mortality associ-
ated with regular mammogram screening
(Nystrom et al. 2002; Olsen and Gotzsche
2001). Epidemiologists have good reason to be
cautious about a relatively modest risk increase
observed in a single study with a poorly under-
stood exposure measure. Given the potentially
enormous public health implications, however,
we believe a substantial investment in follow-
up is appropriate.
Follow-up research currently under way is
investigating possible interactions between
exposure and genetic susceptibility. This
approach is consistent with the precautionary
principle call to study vulnerable populations,
and it may yield additional information of
value for prevention.
Cape Cod study. In the Cape Cod study,
the activists’ request for state funds for an
unusual 3-year scoping and planning process
helped deﬁne the research questions. During
this phase, the study team formed a public advi-
sory committee and a scientiﬁc advisory com-
mittee, established a ﬁeld ofﬁce on Cape Cod,
and conducted focus groups that included
physicians, nurses, women with breast cancer,
and long-time residents. We reviewed scientiﬁc
literature, analyzed existing Cape Cod environ-
mental and epidemiologic data, conducted pilot
environmental studies, and developed new
methodologies suited to the nascent research
questions.
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the convergence of public and scientiﬁc prior-
ities. Usually, study questions and protocols
are defined by researchers (in investigator-
initiated programs) or by funding agencies (in
RFAs). Thus, the development of the research
ideas, goals, and methods precedes formal
funding of the study, making it more difﬁcult
for scientists and the community members to
debate together the research agenda at this
crucial design stage.
The Cape Cod study team reviewed nine
issue areas—ranging from local food distribu-
tion systems to military facilities—as candi-
dates for study and set priorities based on three
criteria: scientiﬁc literature showing a plausible
link to breast cancer; evidence of exposure on
Cape Cod, particularly distinctive exposure;
and community concern. Scientific evidence
included laboratory studies of animal models
and cellular mechanisms and epidemiologic
studies. These criteria and types of evidence
provide widely applicable guidelines for select-
ing research questions under the precautionary
principle, because they emphasize assessing
plausibility in situations in which proof is
unlikely to be achievable. Including commu-
nity concern as a decision-making criterion
helps avoid studies that, although elegantly
designed, do not answer relevant questions, a
pitfall sometimes referred to as a type III error
(Tickner 2003).
The scoping process also incorporated
surveillance and ecologic epidemiology to
reﬁne the deﬁnition of the problem and gen-
erate hypotheses. This process illustrates how
a precautionary approach can generate evi-
dence that appropriately reduces public con-
cern in some areas and focuses attention on
more promising hypotheses. Using GIS tech-
nology, we integrated breast cancer and envi-
ronmental data and searched for geographic
and temporal patterns. We geocoded home
addresses from the Massachusetts Cancer
Registry of about 2,600 Cape Cod women
diagnosed between 1982 and 1994 and used
U.S. Census data and population growth
models to estimate age-adjusted standardized
incidence ratios annually by census block
group (Silent Spring Institute 1997).
Results showed consistently higher inci-
dence rates on Cape Cod than in the rest of the
state; rates of “early” stage 1 diagnosis and
mammography could not account for the
higher incidence rates (Silent Spring Institute
1997, 2004). Mapping revealed that exposure
of residences to electromagnetic ﬁelds (EMFs)
from power lines was uncommon and regional
high incidence was not localized around the
military reservation or nuclear power plant.
These population-level analyses conﬁrmed sus-
picions that elevated breast cancer risk on Cape
Cod was signiﬁcant and long-standing; refo-
cused public attention away from the military
reservation, nuclear plant, and power line
EMFs as the cause; and developed the GIS that
would later be used for individual-level expo-
sure assessments.
Phase 1 also included an innovative ﬁeld
study of EDCs in Cape Cod wastewater,
groundwater, and drinking water to assess the
plausibility of exposure from drinking water
wells affected by septic systems. This aspect of
the study had several characteristics designed
to meet community precautionary goals. It
was small in scope, with 12 groundwater and
wastewater samples and 28 drinking water
samples designed to assess plausibility rather
than to establish representative results. It cast a
broad net by testing for 29 target compounds;
was integrative in that it used an in vitro bio-
assay of estrogen-sensitive cells—the E-Screen
bioassay—to assess total estrogenicity (Soto
et al. 1995); and used low detection limits,
often below regulatory thresholds. The study
contributed to a new field of inquiry by
reporting the ﬁrst measurements of estrogenic
activity in groundwater, supplementing previ-
ous research on surface water (Silent Spring
Institute 1997). And the study had local as
well as national signiﬁcance because land use
and wastewater management policies to pro-
tect drinking water are under active discussion
on Cape Cod. Results showed high levels of
estrogenic alkylphenols in wastewater and
groundwater and low levels in a small number
of private wells, documenting an exposure
pathway through drinking water (Rudel et al.
1998).
During phase 1, the study team updated
community members and local officials
through quarterly meetings of the public
advisory committee, legislative brieﬁngs, and
“poster sessions” where scientists and commu-
nity members could interact informally to
respond to community concerns. At the close
of phase 1, the scientiﬁc team prepared tech-
nical and lay documentation and atlases of
health and environmental data (Silent Spring
Institute 2004). The drinking-water quality
data page in the atlas has become the second
most visited page in the Silent Spring
Institute website, which hosts 400,000 visits
per year. Based on the phase 1 assessment, the
study team recommended further investiga-
tion of EDCs, particularly from wide-area
pesticide use and wastewater-contaminated
drinking water.
The second phase began in 1997 with a
new competitive bidding process in which
MDPH specified a cohort or case–control
study (MDPH 1997), although the 3-year time
frame argued against a cohort study. Silent
Spring Institute won funding for a case–control
epidemiologic study, which ultimately included
2,100 Cape Cod women and an environmental
sampling study of 89 EDCs in air, dust, and
women’s urine from 120 homes. Negotiation
of the ﬁnal study protocol revealed contrasting
perspectives between the activist-scientist team
and MDPH. For example, MDPH required
that the proposed research questions be recast as
statements of null hypotheses, a more yes-or-no
approach than the study team thought best ﬁt
the state of the science. The state also declined
to fund research in a comparison geographic
area off Cape Cod—a decision, perhaps moti-
vated mostly by cost concerns, that fundamen-
tally precluded answering the public’s original
question: Why is breast cancer incidence higher
on Cape Cod? Other proposed elements that
were not funded included soil sampling to vali-
date the GIS-based pesticide exposure estimates
(Brody et al. 2002) and additional testing of
groundwater and drinking water to follow up
on phase 1 ﬁndings of high concentrations of
EDCs in groundwater, a research area with
potentially far-reaching and expensive public
health policy implications.
Nevertheless, the study retained many ele-
ments of a scientiﬁc approach focused on pre-
cautionary strength-of-evidence goals. The
study’s scientiﬁc publications have addressed
seven core research questions, more than half of
which focus on exposure assessment: a) What is
the history of exposure to wastewater contami-
nants (particularly EDCs) in public and private
drinking water (Swartz et al. 2003)? b) What is
the history of exposure to pesticides from wide-
area application (Brody et al. 2002)? c) What
EDCs are women exposed to at home (Rudel
et al. 2003)? d) How do EDCs from septic sys-
tems travel in groundwater, which supplies
drinking water (Rudel et al. 1998)? e) After
controlling for established risk factors, is living
longer on Cape Cod associated with breast can-
cer risk (McKelvey et al. 2003)? f) Is exposure
to pesticides from wide-area application associ-
ated with breast cancer risk (Brody et al. 2004)?
g) Is exposure to drinking water contaminants
associated with breast cancer risk (Brody JG,
Aschengrau A, McKelvey W, et al., unpub-
lished observations)?
The exposure questions are key because
they are critical in assessing plausibility (with-
out exposure to a causal agent, there is no
health effect), they are prerequisite to health
studies, and they identify preventable expo-
sures that could be reduced by precautionary
policies, even in the absence of strong evi-
dence of harm.
Ideally, a breast cancer study would esti-
mate exposures years before diagnosis and at
particular times in the life cycle. Retrospective
self-reporting can offer this standard for expo-
sures that women themselves can identify and
are likely to report without bias, such as the
year and their age at the births of their chil-
dren, which reveals that pregnancy within
5 years of diagnosis and older age at the birth
of a ﬁrst child both increase breast cancer risk
(Bernstein 2002). To approach this goal for
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report, Silent Spring Institute developed GIS
methods to map pesticide drift and drinking
water contamination from historical records
(Brody et al. 2002; Swartz et al. 2003) and
incorporated these assessments with interview
data (Brody et al. 2004). We also estimated
the consequences of uncertainty in the expo-
sure assessment by using sensitivity analyses.
Missing environmental data and a lack of pre-
cision in address histories form the primary
limitations in GIS exposure assessments, so
future studies could be strengthened by the sys-
tematic geographic tracking of environmental
data and the ascertainment of address histories
at the time of reportable diagnoses, such as
cancer (Hurley et al. 2003; Wakeﬁeld 2000).
Although the GIS exposure assessment is
valuable for developing new methods for pub-
lic health studies, its application in the Cape
Cod study shares with the Long Island study
the risk of generating findings that are diffi-
cult to interpret because of uncertainties in
the exposure assessment. Indeed, the results
have been ambiguous. We found no consis-
tent association between pesticides and breast
cancer and weak evidence of associations with
certain types of pesticide use (Brody et al.
2004). After controlling for established breast
cancer risk factors, however, we did ﬁnd that
living longer on Cape Cod is significantly
associated with higher breast cancer risk
(McKelvey et al. 2003). This “black box epi-
demiology” (Greenland et al. 2004) result
provides convincing evidence that an addi-
tional regional risk factor remains to be dis-
covered but offers no further guidance on
where to look.
Parallel to the drinking water sampling
in phase 1, phase 2 included monitoring of
EDC exposures in homes with these goals:
identify common exposures, including mix-
tures, for toxicologic and epidemiologic study
and regulation; identify the products or prac-
tices that lead to common exposures; identify
factors that contribute to high-end exposures;
test methods to reduce contaminant levels by
changing product use and other practices; and
develop methods of exposure assessment for
future health studies.
The household exposure study has not
been linked to health outcomes in the epi-
demiologic study because of low statistical
power for that purpose, and information on
the health significance of these exposures is
not available. This strategy of broadly study-
ing exposure without an identiﬁed health out-
come is atypical in public health studies—
perhaps because health officials are uncom-
fortable dealing with the uncertain action
implications of reporting on exposure without
an established tie to health—but it has
received strong scientific and public interest
(e.g., Betts 2003; Cone 2003). This approach
produced the ﬁrst reported indoor concentra-
tions for 30 pollutants and data directly rele-
vant to public health debates, such as the use
of polybrominated diphenyl ethers as flame
retardants.
State funding for environmental sampling
in the Cape Cod study resulted from advocacy
by MBCC, and breast cancer activist organi-
zations also have provided financial support
for the work. Recently, the household expo-
sure study has become a point of connection
between breast cancer advocacy and other
health-affected groups. For example, the study
team is currently collaborating with Brown
University researchers and Communities for a
Better Environment (Oakland, CA), a com-
munity-based environmental justice organiza-
tion, to apply the methods in a low-income,
ethnic-minority fenceline community, where
the immediate focus will be on whether expo-
sure data can be useful in evaluating emissions
limits, ﬂare rules, and emergency procedures.
NIEHS Centers. Still in a relatively early
stage of development, the NIEHS Breast
Cancer Centers and the Environment Research
Centers were initiated with several important
elements consistent with the precautionary
principle. First, the RFA speciﬁed girls’ devel-
opment through puberty as the health out-
come, which represents a breakthrough in
moving “upstream” in breast cancer research.
Early age at puberty is a well-established risk
factor for breast cancer, and age at puberty is
falling, particularly among African-American
girls, a group at greater risk than whites for
breast cancer mortality, though not incidence
(Bernstein et al. 2003; Krieger 2002). In addi-
tion, researchers hypothesize that rapid breast
cell proliferation during adolescence may make
this a critical exposure period. Thus, research
questions about adolescence resonate with the
precautionary principle because they address
vulnerable populations, allow investigation of
subtle and complex phenomena, and con-
tribute to the understanding of the natural
development process.
By including a laboratory research compo-
nent as well, the centers elucidate biologic
mechanisms, an important element in assessing
plausibility, and develop tools for screening
and testing chemicals for possible regulation.
The laboratory component also facilitates
research on a longer list of chemicals than the
epidemiologic study. The RFA did not, how-
ever, speciﬁcally call for an investment in expo-
sure assessment, although the lack of such
methods is a significant barrier to studying
EDCs (Rudel et al. 1998, 2001). The epidemi-
ologic study will evaluate the EDCs bisphenol
A, dioxin, and di(2-ethylhexyl) phthalate, as
well as individual factors such as diet and body
size. The study will bank biologic specimens,
an increasingly common practice, so that
researchers can “try again” as science advances,
a strategy that may improve the payback on
investments in large epidemiologic studies.
The centers’ steering committee, composed
of scientist and advocate representatives, inte-
grates epidemiologic and laboratory work,
scientist and activist perspectives, and the inter-
ests of the different centers. This management
approach represents innovation in both science
and public involvement. The centers program
recently held its ﬁrst scientist–advocate confer-
ence (Russo 2004), at which both scientists
and breast cancer activists were session chairs
and presenters.
Conclusion
As the continuing increase in breast cancer inci-
dence sparked activist demands for prevention-
oriented research, laboratory evidence that
many common pollutants are mammary car-
cinogens and/or EDCs provided new hypo-
theses about environmental factors. But the
challenges in assessing relevant exposures to
pollutants in a breast cancer study meant a
mismatch between activist goals and the sci-
entiﬁc methods typically used in investigator-
initiated epidemiologic studies. By examining
recent research—the Long Island and Cape
Cod breast cancer and environment studies
and the new NIEHS Centers—we can draw
lessons for many public health problems for
which scientiﬁc uncertainty is likely to persist.
Each of these studies contributes novel
public involvement methods and increases
transparency in public health science, provid-
ing new models for community-based partici-
patory research. Activists used legislation and
appropriations processes to direct scientific
inquiry and, in Massachusetts, founded the
Silent Spring Institute as a scientiﬁc team with
activist participation in governance. The 3-year
scoping process in the Cape Cod study pro-
vided an opportunity to review scientiﬁc plau-
sibility of multiple hypotheses, allowing activist
and scientist perspectives to converge.
Far from hindering science, the involve-
ment of breast cancer activists has helped
drive scientiﬁc innovation, particularly in the
development and application of exposure
assessment methods. Environmental and bio-
logic sampling methods can identify common
mixtures for further study and inform precau-
tionary exposure reduction. GIS methods can
assess historical exposures that women cannot
report. The suggestive positive result for PAHs
in the Long Island study provides the impetus
for policies to reduce ubiquitous PAH expo-
sure. At the same time, however, unresolved
weaknesses in exposure assessment methodolo-
gies have hindered the success of epidemiologic
components of the research programs, because
they mean that negative results are insufﬁcient
to conclude that no relationship exists.
Breast cancer activists were among the
ﬁrst and most powerful health-affected groups
Brody et al.
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to make environmental research and preven-
tion a priority. The resulting studies provide
paradigmatic models for public health science
for diseases whose links to environmental fac-
tors are difficult to prove. They argue for
greater emphasis on exposure studies before
undertaking health studies and on laboratory
research on questions that do not lend them-
selves to human research. Yet they leave
unanswered questions about when to invest in
traditional epidemiologic studies, when nega-
tive results are sufﬁcient, and how to pursue
ambiguous positive results in further research
and policy.
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